FDA Inspection 783164 — Salix Pharmaceuticals Inc
The FDA completed an inspection of Salix Pharmaceuticals Inc on May 23, 2012 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 23, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Raleigh, NC (United States)
Additional details
Sponsor, Contract Research Organization